Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Cardiovascular DiseasesRetina; Change
Interventions
DIAGNOSTIC_TEST

Swept Source Optical Coherence Tomography Angiography

The PLEX Elite 9000 is an FDA cleared research device for use in ocular imaging obtained by Northwestern University by way of a purchase agreement with the manufacturer, Carl Zeiss Meditec, Inc. It is currently unavailable outside of participation in the ARI Network, a cloudbased storage and image processing platform using deidentified information shared between academic institutions. The ARI Network is managed by a group of physicians and scientists from around the world that are working to better understand eye diseases.

Trial Locations (1)

60611

RECRUITING

Northwestern University/Northwestern Medical Group, Department of Ophthalmology, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER